BRIAN BONFARDIN: Open Payments
NPI 1356322515 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768,585 in 838 payments from 11 companies in 2025. Trend: 2023 $377,287 · 2024 $582,618 · 2025 $768,585
Speaker / faculty: $568,313Honoraria: $103,550Travel & lodging: $59,327Consulting: $23,165Food & beverage: $14,230
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 285 | $226,904 |
| ABBVIE INC. | 142 | $135,138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 96 | $110,743 |
| Axsome Therapeutics, Inc. | 90 | $102,407 |
| Otsuka America Pharmaceutical, Inc. | 93 | $91,942 |
| Alkermes, Inc. | 83 | $63,744 |
| E.R. Squibb & Sons, L.L.C. | 37 | $28,398 |
| Supernus Pharmaceuticals, Inc. | 8 | $9,247 |
| Lundbeck LLC | 2 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: FANAPT, VRAYLAR, CAPLYTA, Auvelity, LYBALVI, REXULTI, ABILIFY MAINTENA, COBENFY.
Industry payments across TN — which companies pay providers there.
